Background
==========

Chylous pericardial effusion may occur following cardiothoracic surgery or in association with congenital lymphangiomatosis. Other causes may include chest trauma, mediastinal irradiation, malignant diseases, filariasis and thrombosis of the subclavian vein and superior vena cava. Primary chylopericardium has also been described, most commonly in children and young adults \[[@B1]\]. Thirty three cases were identified from 31 articles through a systematic literature search.

Herein, a case of spontaneous chylous cardiac tamponade which was successfully treated by video-assisted thoracic surgery (VATS) is reported.

Case presentation
=================

A 41-year-old female was admitted to our hospital with shortness of breath for about 24 hours. There was no significant past medical or surgical history except for the fact that she experienced a painful hyperextension of the spine the previous morning, during routine physical exercise. A subsequent chest x-ray showed enlargement of the cardiac silhouette (Figure [1](#F1){ref-type="fig"}).

![**Preoperative chest x-ray demonstrating cardiac enlargement due to pericardial effusion**.](1749-8090-5-11-1){#F1}

A transthoracic echocardiogram demonstrated a large pericardial effusion, with right ventricular collapse consistent with cardiac tamponade physiology. An urgent therapeutic pericardiocentesis was performed and 1200 ml of milky fluid was removed and an 8 Fr drain was left in place. The laboratory results of the fluid revealed the following: triglycerides 550 mg/dl, cholesterol 110 mg/dl, total proteins 4.6 g/dl, glucose 85 mg/dl. The diagnosis of chylopericardium was established. Cytology stains and cultures were all unremarkable. Blood tests for rheumatologic, endocrinologic and autoimmune disorders were normal. Tests for bacterial, fungal, mycobacterial and viral infections were also conducted and found negative. Chest, abdomen and brain scans were normal. No evidence of lymphadenopathy was noted. Despite the absence of severe symptomatology concerning the spine injury a magnetic resonance imaging of the thoracic spine was ordered and was consistent with a disruption of the anterior longitudinal ligament and anterior protrusion of the intervertebral disc (Figure [2](#F2){ref-type="fig"}).

![**Magnetic resonance imaging was consistent with a disruption of the anterior longitudinal ligament and anterior protrusion of the intervertebral disc (black arrow)**.](1749-8090-5-11-2){#F2}

A daily output of 350 ml of pericardial fluid led us to start total parenteral nutrition, subcutaneous octreotide and no oral feedings for 7 days. These conservative measures proved to be unsuccessful because the rate of the pericardial drainage did not decrease. The patient also underwent, a bipedal lymphangiography which showed no anatomic abnormalities of the thoracic duct and no leakage. Under these circumstances the patient was addressed for thoracic surgical evaluation. The patient finally underwent a video-assisted supradiaphragmatic mass ligation of the thoracic duct and creation of a pleuropericardial window through a low right mini thoracotomy. Ligation of the thoracic duct together with all the adjacent soft tissue between the esophagus, the azygos vein and the aorta was performed. The patient was recovered uneventfully for both spine injury and tamponade. There has been no recurrence of the pericardial effusion for 12 months.

Discussion
==========

Chylopericardium is sometimes a consequence of thoracic and cardiac surgery. It may also occur as a result of chest trauma, mediastinal neoplasms, mediastinal tuberculosis, mediastinal radiotherapy, and thrombosis of the subclavian vein \[[@B2]\].

Idiopathic chylopericardium is a rare entity. It was first reported in 1886 by Hasebrock. The term primary isolated chylopericardium was first reported by Groves and Effler in 1954 \[[@B3]\].

Its precise etiology still remains unknown. Primary chylous pericardial effusions result from retrograde flow through abnormal lymphatics into rich pericardial plexus. Such abnormal lymphatic channels may represent lymphangiomas or they may be a part of larger lymphatic tumors \[[@B4]\]. Several mechanisms have been proposed to explain the development of chylous pericardial effusions. Most secondary effusions are caused by interruption of the thoracic duct by surgery, inflammation or non lymphatic tumor. Normal lymphatic valves prevent chylous reflux into the pericardial plexus even after ligation of the thoracic duct proximal to the pericardial tributaries, unless concurrent superior vena caval ligation prevents collateral flow. Blunt chest trauma may rupture lymphatic valves by precipitously elevating intrathoracic pressure \[[@B5]\]. This mechanism caused by the flexion - hyperextension movement of the thoracic spine, could be the underlying mechanism in this case. The problem is that pedal lymphoscintigraphy did not prove any communication between thoracic duct or branches and pericardial sac.

Symptoms depend on the importance of the effusion and on compression of the cardiac cavities. Chronic effusions may remain asymptomatic for a long time. Whenever cardiac compression occurs symptoms are those observed with tamponade and include: exertional dyspnea, chest pain, fatigue and palpitations. Asymptomatic pericardial effusions are usually diagnosed on routine chest x-ray, echocardiography, computerized tomography scan or magnetic resonance imaging.

Chylopericardium is usually diagnosed by pericardiocentesis that shows the presence of chylous fluid with high triglyceride level. Pathological analysis demonstrates white-yellow chylous fluid with numerous foamy cells and fat globules shown by Sudan III staining \[[@B6]\]. Also noted are extra-cellular fat droplets and predominance of lymphocytes \[[@B7]\].

Many diagnostic modalities have been described, including observation of Sudan III dye distribution into the pericardial cavity after oral intake of Sudan III dye, lymphangioscintigraphy, lymphangiography and evaluation of chest radioactivity after an oral dose of 131I-triolein. All of these methods are used to ascertain the cause of the chylous pericardial effusion \[[@B8]\]. According to the literature, demonstrable abnormalities of thoracic lymphatic vessels were present in 4 out of 5 patients who presented with cardiac tamponade and in 1 of 2 patients who developed tamponade after pericardiocentesis \[[@B4]\].

Non surgical management includes dietary regimen with nothing per os or medium chain triglycerides, total parenteral nutrition and subcutaneous octreotide. However this conservative treatment alone is associated with reaccumulation of fluid \[[@B9]\].

Surgical treatment has been proposed to halt recurrence and progression for cardiac tamponade. Surgical modalities include pericardial window formation, thoracic duct ligation and pericardial-peritoneal shunting. The success of combined thoracic duct ligation above the diaphragm and pericardial window has been documented \[[@B9]\]. Furrer and colleagues described the first successful thoracoscopic approach to primary chylopericardium \[[@B1]\]. The authors mentioned a mass ligation of all tissues situated between the azygos vein, vertebral body and descending aorta. This kind of approach was used in our case with excellent results. The left-sided approach has some disadvantages because in the lower thoracic cavity, the thoracic duct is located to the right of the descending aorta. This prevents easy access to the duct when entering from the left hemithorax. The VATS procedure is being used increasingly and is associated with less postoperative pain and pulmonary dysfunction \[[@B10]\].

Conclusions
===========

In conclusion, a rare case of chylous cardiac tamponade probably related to a previous thoracic spine flexion-hyperextension injury was presented. Lymphoscintigraphy failed to prove communication between thoracic duct and pericardial sac. Video-assisted thoracic surgery with pericardial window formation and supradiaphragmatic mass ligation of the thoracic duct was curative.
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